Charles K. Gayer, Chief Commercial Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 6,100 shares at $10.90 ($66K) on 2022-12-15, disclosed to the SEC on 2022-12-19.
Open-market sale of $66k BCRX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.